REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,425,261 | +97061.1% | 348,064 | +42.1% | 0.20% | -9.3% |
| Q3 2022 | $6,613 | +113.9% | 244,917 | +9.5% | 0.22% | +103.8% |
| Q2 2022 | $3,091 | -2.0% | 223,631 | +38.3% | 0.11% | +35.9% |
| Q1 2022 | $3,153 | -10.8% | 161,695 | -25.3% | 0.08% | +6.8% |
| Q4 2021 | $3,533 | -1.1% | 216,497 | +68.8% | 0.07% | +7.4% |
| Q3 2021 | $3,573 | – | 128,239 | – | 0.07% | – |
Download | ||||||